ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,164.12
-0.19%
Dow Jones
39,118.86
-0.12%
Gold vs US Dollar
2,326.73
0.00%
Brent Oil
84.85
0.00%
Bitcoin
60,860.55
0.91%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Unicycive Therapeutics Inc (UNCY) Share Price

UNCY Unicycive Therapeutics Inc

0.514
0.1089 (26.88%)
29 Jun 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Unicycive Therapeutics Inc NASDAQ:UNCY NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.1089 26.88 0.514 0.514 0.5298 0.5013 0.401 0.418 1,663,698 23:58:52   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 675k -31.41M -0.8353 -0.59 18.43M
 Type  Size  Price  Time  Units 
 20 200 0.514 23:58:52 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore UNCY News
25/06/202412:30GLOBEUnicycive Therapeutics Achieves Study Objective in Oxylanthanum Carbonate (OLC) Pivotal Clinical Trial
28/05/202412:03GLOBEUnicycive Therapeutics Delivers Multiple Presentations on Oxylanthanum Carbonate (OLC) and UNI-494 at the European Renal Association Congress
23/05/202412:03GLOBEUnicycive Therapeutics to Participate in a Fireside Chat at the Lytham Partners Spring 2024 Investor Conference
15/05/202412:03GLOBEUnicycive Therapeutics Presents Bioequivalence Data on Oxylanthanum Carbonate (OLC) at the National Kidney Foundation Spring Clinical Meeting
13/05/202421:28EDGAR2Form 8-K - Current report
13/05/202421:16GLOBEUnicycive Announces First Quarter 2024 Financial Results and Provides Business Update
13/05/202421:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Period
Draw mode
Data Downloads for UNCY

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Unicycive Therapeutics Inc Articles